Esther T L Lau1, Michelle E Rochin2, Megan DelDot3, Beverley D Glass4, Lisa M Nissen5. 1. , BPharm(Hons), PhD, GCResComm, GradCertAcadPrac, AACPA, MPS, is with the School of Clinical Sciences, Queensland University of Technology, Brisbane, and the Pharmaceutical Society of Australia (Queensland Branch), Pharmacy Australia Centre of Excellence, Woolloongabba, Queensland, Australia. 2. , BPharm, is with the School of Clinical Sciences, Queensland University of Technology, Brisbane, and the Pharmaceutical Society of Australia (Queensland Branch), Pharmacy Australia Centre of Excellence, Woolloongabba, Queensland, Australia. 3. , BPharm, MClinPharm, MPS, is with the Pharmaceutical Society of Australia (Queensland Branch), Pharmacy Australia Centre of Excellence, Woolloongabba, Queensland, Australia. 4. , BPharm, BSc(Hons), PhD, is with the College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia. 5. , BPharm, PhD, AdvPracPharm, FPS, FHKAPh, FSHP, is with the School of Clinical Sciences, Queensland University of Technology, Brisbane, and the Pharmaceutical Society of Australia (Queensland Branch), Pharmacy Australia Centre of Excellence, Woolloongabba, Queensland, Australia.
Abstract
BACKGROUND: Vaccination is a safe, efficient, and cost-effective means of preventing, controlling, and eradicating many life-threatening infections and diseases. Globally, the World Health Organization estimates that vaccination saves between 2 million and 3 million lives annually. However, low immunization rates are a significant public health concern. Individual factors, along with the vaccination process and system, have been reported as perceived barriers and challenges to immunization. Lack of time, on the part of both health care professionals and patients, has also been reported as a key factor influencing patterns of immunization. Despite the accessibility of pharmacists in community pharmacies in Australia, and initiatives by other countries to introduce pharmacist vaccination services, pharmacists in Australia had not previously delivered this service. The Queensland Pharmacist Immunisation Pilot (QPIP), initially implemented for the 2014 influenza season and later expanded, as QPIP2, to include other vaccines, allowed Australian pharmacists to vaccinate for the first time. OBJECTIVES: To develop, implement, and evaluate a training program for pharmacists undertaking vaccination services in community pharmacies in Australia. METHODS: Background content was developed and delivered through 2 online modules. Pharmacists were required to successfully answer a series of multiple-choice questions related to the background reading before attending a face-to-face workshop. The workshop provided practical training in injection skills and anaphylaxis management. Participants were also asked to evaluate the training program. RESULTS: Of the 339 pharmacists who completed the training program, 286 (84%) provided an evaluation. Participants were satisfied with the training, as indicated by consistently high scores on the "overall satisfaction" question (mean 4.65/5 for the QPIP and QPIP2 training combined). Participants described the background reading as relevant to their practice and stated that it met their expectations. They also valued the opportunity to practise injections on each other during the face-to-face workshop, and this aspect was noted as a key component of the training. CONCLUSIONS: QPIP demonstrated that a pharmacist-specific training program could produce competent and confident immunizers and could be used to "retrofit" the profession, to facilitate delivery of vaccination services in Australia.
BACKGROUND: Vaccination is a safe, efficient, and cost-effective means of preventing, controlling, and eradicating many life-threatening infections and diseases. Globally, the World Health Organization estimates that vaccination saves between 2 million and 3 million lives annually. However, low immunization rates are a significant public health concern. Individual factors, along with the vaccination process and system, have been reported as perceived barriers and challenges to immunization. Lack of time, on the part of both health care professionals and patients, has also been reported as a key factor influencing patterns of immunization. Despite the accessibility of pharmacists in community pharmacies in Australia, and initiatives by other countries to introduce pharmacist vaccination services, pharmacists in Australia had not previously delivered this service. The Queensland Pharmacist Immunisation Pilot (QPIP), initially implemented for the 2014 influenza season and later expanded, as QPIP2, to include other vaccines, allowed Australian pharmacists to vaccinate for the first time. OBJECTIVES: To develop, implement, and evaluate a training program for pharmacists undertaking vaccination services in community pharmacies in Australia. METHODS: Background content was developed and delivered through 2 online modules. Pharmacists were required to successfully answer a series of multiple-choice questions related to the background reading before attending a face-to-face workshop. The workshop provided practical training in injection skills and anaphylaxis management. Participants were also asked to evaluate the training program. RESULTS: Of the 339 pharmacists who completed the training program, 286 (84%) provided an evaluation. Participants were satisfied with the training, as indicated by consistently high scores on the "overall satisfaction" question (mean 4.65/5 for the QPIP and QPIP2 training combined). Participants described the background reading as relevant to their practice and stated that it met their expectations. They also valued the opportunity to practise injections on each other during the face-to-face workshop, and this aspect was noted as a key component of the training. CONCLUSIONS: QPIP demonstrated that a pharmacist-specific training program could produce competent and confident immunizers and could be used to "retrofit" the profession, to facilitate delivery of vaccination services in Australia.
Authors: Sarah A Buchan; Laura C Rosella; Michael Finkelstein; David Juurlink; Jennifer Isenor; Fawziah Marra; Anik Patel; Margaret L Russell; Susan Quach; Nancy Waite; Jeffrey C Kwong Journal: CMAJ Date: 2016-08-08 Impact factor: 8.262
Authors: Dorothee Elsbeth Michel; Ayesha Iqbal; Laura Faehrmann; Ivana Tadić; Ema Paulino; Timothy F Chen; Joanna C Moullin Journal: Int J Clin Pharm Date: 2021-10-11